Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minguez JR, Meerkin D, Valdés M, Ormerod O, Leithäuser B (2011) Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 77:700–706

    PubMed  Article  Google Scholar 

  3. 3.

    Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, Clugston R, Yong G, Gattorna T, Paul V (2012) Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 79:794–800

    PubMed  Article  Google Scholar 

  4. 4.

    Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM (2003) Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 60:417–422

    PubMed  Article  Google Scholar 

  5. 5.

    Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H (2005) Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 46:9–14

    PubMed  Article  Google Scholar 

  6. 6.

    Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S (2011) Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 123:417–424

    PubMed  Article  Google Scholar 

  7. 7.

    Jabs A, Hink U, Warnholtz A (2012) Stephan von Bardeleben R, Nikolai P, Münzel T, Gori T. Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation. Clin Res Cardiol 101(5):393–396

    PubMed  Article  Google Scholar 

  8. 8.

    Sedaghat A, Nickenig G, Hammerstingl C (2014) Left atrial appendage closure in a patient with atrial fibrillation after mechanical mitral valve replacement and cardio-embolic stroke despite effective oral anticoagulant therapy: a case report. Clin Res Cardiol 103:10–12

  9. 9.

    Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R, Holmes D, Reddy VY (2012) The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) Substudy. J Am Coll Cardiol 59:923–929

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Koji Hanazawa.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (MP4 1771 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hanazawa, K., Brunelli, M. & Geller, J.C. Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure. Clin Res Cardiol 103, 835–837 (2014). https://doi.org/10.1007/s00392-014-0724-0

Download citation

Keywords

  • Dabigatran
  • Thromboembolic Complication
  • Leave Atrial Appendage
  • Mitral Valve Disease
  • Residual Flow